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Abstract Uterine polyps can cause abnormal bleeding in
women. Conventional practise is to remove them under general
anaesthesia but advances in technology have made it possible
to perform polypectomy in the office setting. We conducted a
patient-preference study to explore women’s preferences for
treatment setting and to evaluate the effectiveness and treatment
experience of women undergoing uterine polypectomy. Three
hundred ninety-nine women with abnormal uterine bleeding
who were found to have uterine polyps at diagnostic hysteros-
copy were recruited. Office polypectomies were performed in
office hysteroscopy clinics, and inpatient procedures were un-
dertaken in operating theatres. Three hundred twenty-four of
399 (81 %) expressed a preference for office treatment. There
was no difference found between office treatment and inpatient
treatment in terms of alleviating abnormal uterine bleeding as
assessed by patients and in improving disease-specific quality
of life. Acceptability was lower and patient pain scores were
significantly higher in the office group. When offered a choice
of treatment setting for uterine polypectomy, patients have a
preference for office over inpatient treatment. Ambulatory gy-
naecology services should be available within healthcare sys-
tems to meet patient demand.
Keywords Office polypectomy .Abnormal uterine bleeding .
Patient preference . Ambulatory gynaecology . Uterine polyp
Introduction
Abnormal uterine bleeding affects women of all ages and is
the commonest reason for referral to secondary care [1, 2].
Uterine polyps are commonly found in association with ab-
normal uterine bleeding in both pre- and postmenopausal
women [3–7] when investigated with ultrasound or office
hysteroscopy. Whilst the risk of occult malignancy within
uterine polyps is low, the available evidence supports the cur-
rent practise of surgically removing uterine polyps to help
alleviate bleeding symptoms [8, 9] and this has traditionally
been performed under general anaesthesia. However, with ad-
vances in endoscopic technology, it is now possible to perform
uterine polypectomy under hysteroscopic guidance in an of-
fice setting without the need for hospital admission and anaes-
thesia [10–12]. Furthermore, treatment can be carried out at
the same time as diagnosis; the “see & treat” approach [13].
Whilst recruiting to a randomised controlled non-inferiority
study which compared office to inpatient polypectomy, we col-
lected data from women who consented to be followed-up, but
had a preference for how they were treated and so could not be
randomised. We designed this parallel observational study
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because a pilot RCT to aid the final office polyp treatment
(OPT) study design (www.birmingham.ac.uk/research/
activity/mds/trials/bctu/trials/womens/opt/index.aspx) had
suggested that a substantial proportion of women would exert
a preference for treatment setting. We therefore wanted to
explore women’s preferences for treatment setting and to
evaluate the effectiveness and treatment experience of women
when undergoing uterine polypectomy for alleviating abnormal
bleeding according to their preference.
Methods
Population
All women with abnormal uterine bleeding and a uterine pol-
yp diagnosed at office hysteroscopy [13] were eligible to be
recruited into the office polyp treatment (OPT) study. Women
in equipoise were recruited to the randomised study [14] and
those with a preference for treatment were asked to participate
in the preference study as we describe here. Abnormal uterine
bleeding included heavy menstrual bleeding, intermenstrual
bleeding and postmenopausal bleeding. Women were exclud-
ed if office polypectomy was considered not feasible, malig-
nancy was suspected or another surgical uterine intervention
was needed. All participants provided written informed con-
sent. In clinics which provided a ‘see and treat’ service, con-
sent was obtained and the patient was registered on the on-line
recruitment system prior to the diagnostic hysteroscopy, so
that if a uterine polyp was diagnosed and the woman’s prefer-
ence was for office polypectomy, treatment could be per-
formed straight away without an interruption to register the
patient into the study.
Procedures
Following the diagnostic hysteroscopy, women who agreed to
participate in the preference study had their choice of treatment
arranged. Those who chose office polypectomy underwent the
procedure immediately following diagnosis in most instances,
although some participants had their treatment scheduled with-
in the following 8 weeks. Office polypectomies were per-
formed in the office hysteroscopy clinic and inpatient proce-
dures were performed in operating theatres, under general or
regional anaesthesia. Office polyp removal was carried out un-
der direct hysteroscopic vision using miniature mechanical
(scissors, biopsy cups and grasping forceps) or electrosurgical
instruments (bipolar electrodes), with or without the need for
minor degrees of cervical dilatation and local anaesthesia (di-
rect cervical infiltration or paracervical injection). Blind avul-
sion with small polypectomy forceps was also allowed.
Womenwho chose inpatient polypectomy could have tradition-
al dilatation and curettage or removal under vision using a
resectoscope. Clinicians were free to choose the operative tech-
nique for polypectomy. Endometrial biopsy and medical ther-
apies were permitted when indicated.
Outcome measures and follow-up
Our main measure of interest was successful treatment, deter-
mined by the women’s assessment of their bleeding at
6 months using a dichotomous (success/fail) outcome mea-
sure. For women with heavy menstrual bleeding, treatment
was considered a success if bleeding had reduced to accept-
able levels. For women with intermenstrual or postmenopaus-
al bleeding, the definition was cessation of bleeding.
Other patient reported outcome measures were the women’s
subjective assessment of their bleeding using visual-analogue-
scales (0 for no bleeding to 100 heaviest imaginable and 0 for
no days bleeding to 100 bleeding every day) and response to
the question ‘compared to before your treatment, would you
say your bleeding is?’ on an ordered Likert scale (much better,
little better, same, worse). Health-related-quality-of-life was
measured using the generic EuroQol EQ-5D-3L [15] and the
disease-specific Menorrhagia Multi-Attribute Scale (MMAS)
[16]. All clinical data were collected at baseline and then by
mail at 6 months post recruitment.
Patient experience was also evaluated; patients were asked
to rate their level of pain 1 h after the procedure and on dis-
charge from hospital using visual-analogue-scales (0 no pain
to 100 worst imaginable pain). Women undergoing office
polypectomy also rated the level of pain during the procedure.
Acceptability of the procedure was assessed using Likert
scales and structured questions. This was supplemented by a
series of semi-structured qualitative telephone interviews in a
purposive sample of women (who had consented to be
interviewed) 1 week after the procedure. Rates of successful
polyp removal and complications were recorded peri-opera-
tively, and postoperative data were collected for adverse
events and need further treatment.
Statistical analysis
Analyses were performed including all consenting partici-
pants in the group of their preference regardless of whether
they received their preference, or indeed any, treatment (i.e.
intention–to-treat). Chi-squared and t tests were used to assess
if there were any systematic differences between the prefer-
ence groups in terms of their baseline characteristics. Odds
ratios for successful treatment at 6 month were generated
using a logistic regression model (odds ratios were favoured
over risk ratios as it is more straightforward to generate stable
adjusted estimates [17]. Estimates were adjusted for potential
confounders that were considered to be the most clinically
important by adding the following 12 variables to the model:
predominant bleeding complaint at consent (post-
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menopausal/heavy menstrual/intermenstrual), site of uterine
polyp (fundal/non-fundal), type of uterine polyp (glandular/
fibrous), number of polyps (1/2/3+), largest polyp size (con-
tinuous variable), grade of surgeon (consultant/less experi-
enced), removal technique (blind/hysteroscopic), detachment
technique (electrode/mechanical), age (continuous variable),
body mass index (continuous variable), parity (0/1/2/3/4+),
and centre of recruitment (Birmingham Women’s Hospital/
Royal Hallamshire Hospital Sheffield/other minor centre). A
multiple imputation procedure [18] (assumed data was miss-
ing at random) was used in this analysis to impute any missing
data items. Variables in the imputation model included the
outcome variable of interest together with the parameters
listed above; 20 imputed data sets were created using the
MCMC method with overall estimates and standard error cal-
culated using Rubin’s rules [19]. 95 % confidence intervals
were generated along with a p value from the associated two-
sided chi-squared test. Other binary outcomes and endpoints
measured on a continuous scale (scores fromMMAS, EQ-5D
and VAS scores) were analysed in a similar fashion to the
above (linear regression model adjusting for baseline score
for continuous variables). Unadjusted estimates are provided
for comparison or where an adjustment was not possible be-
cause of low group frequencies. No adjustments were made
for operative descriptors. Standard tests were used for other
outcome measures: paired t tests for changes from baseline
scores within groups and two-sample t tests for continuous
data with a normal distribution, Wilcoxon signed rank test
for skewed continuous data and chi-squared tests for binary
and categorical responses. SAS version 9.2 was used for anal-
yses (PROC MI for the multiple imputation procedure).
Results
Recruitment and qualitative assessment of patients’
preference for treatment
Between April 2008 and July 2011, in 30 UK NHS centres,
952 women with abnormal uterine bleeding and a preference
for how they wanted to be treated agreed to participate. Three
hundred ninety-nine (42 %) women were recruited with the
main reason for ineligibility being no polyp present at diag-
nostic hysteroscopy. Three hundred twenty-four of 399 (81%)
expressed a preference for office treatment (Fig. 1).
Thirteen women underwent qualitative interviews. Women
were asked about their treatment preferences, which were
mainly down to individual reasons. Most women choosing
office treatment wanted it over and done within one hospital
visit, and even though for one of these women the procedure
could not be completed she still thought it was the right choice.
Of the other women, two had a fear of anaesthetics, one had a
pre-existing medical condition, one had children to make
arrangements for and one did not want to take time off work.
Very fewwomen in the overall preference study chose inpatient
treatment and the four interviewed all spoke of a previous bad
experience of hysteroscopy or other procedures under local
anaesthetic, or embarrassment at being in stirrups, which made
them want a general anaesthetic. In both groups of the study, a
number of women told of how they had consulted friends and
family before attending the clinic, or the nurse in the clinic, in
order to make a decision about the procedure, but this had to be
weighed up against their personal feelings.
Participants and follow-up
There were no statistically significant differences between
groups in the baseline characteristics of the women
(Table 1). Overall, for 48 % (192/399) of the women, the
initial complaint was postmenopausal bleeding; 25 % (98/
399) had heavy menstrual bleeding and the remaining partic-
ipants had intermenstrual bleeding, 109/399 (27 %). Three
hundred two of 324 (93 %) of the office group received their
treatment preference compared with 68/75 (91 %) of the in-
patient group (Fig. 1). Sixty-three percent of the women allo-
cated to office polypectomy were treated in ‘see and treat’
clinics. The median time from recruitment to treatment in
the office groups and inpatient group were 0 days (IQR = 0,
27) and 31 days (IQR = 7, 55), respectively. Completed pri-
mary outcome responses were available from 338/399 (85 %)
of participants at 6 months (Fig. 1).
Treatment success
There was no significant difference between treatment success
in the office and inpatient polypectomy groups with 82 % in
each group reporting successful alleviation of bleeding symp-
toms at 6 months (231/283 versus 45/55, unadjusted
OR = 0.99, 95 % CI = 0.47, 2.09; p > 0.9; adjusted
OR = 1.12, 95 % CI = 0.47, 2.69; p = 0.8).
Operative results
Table 2 details the operative and postoperative results details.
Office treatment required less vaginal instrumentation
(OR = 0.13, 95 % CI = 0.06, 0.31; p < 0.001) and dilatation
of the cervix (OR = 0.15, 95 % CI = 0.08, 0.28; p < 0.001).
Hysteroscopic polypectomy under direct vision was signifi-
cantly more common (OR = 3.6, 95 % CI = 2.0, 6.4;
p < 0.001) in the office setting, with electrosurgery being the
most popular method of detaching polyps (OR = 2.0, 95 %
CI = 1.2, 3.5; p = 0.02). Hysteroscopic retrieval of specimens
from the uterine cavity was the most common technique in the
office setting whereas blind mechanical extraction was pre-
ferred in the inpatient group (OR = 5.6, 95 % CI = 3.0, 10.4;
p < 0.001). The proportion of complete removals was not
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significantly different between groups (282/312 [90 %] versus
68/73 [93 %], unadjusted OR = 1.4, 95 % CI = 0.5, 3.9;
p = 0.5; adjusted OR = 1.9, 95 % CI = 0.7, 5.6; p = 0.2).
Serious adverse events
No serious adverse events occurred in the preference study.
The most common perioperative complications in the office
group were induced vaso-vagal reactions affecting 6 % of the
cohort. Vaso-vagal reactions also occurred postoperatively
with a similar percentage in each cohort (5 % of the office
group versus 3 % of the inpatient group) (Table 2).
Quality of life and bleeding scores
Condition-specific quality of life and bleeding scores were sig-
nificantly improved from baseline at 6 months in both groups
with no significant differences between them (Table 3). Generic
quality of life scores (Euroqol EQ-5D) were improved from
baseline in the office group but not in the inpatient group with
no difference between the groups at 6 months. The non-
significant increase within the inpatient group may be due to
the relatively small number of women in this group.
Procedure acceptability
Mean pain scores were significantly higher in the office
polypectomy group compared with the inpatient group at
1-h post procedure and on discharge (Table 3). Two percent
(7/299) of women in the office group compared with no wom-
en in the inpatient group felt that the procedure they
underwent was ‘unacceptable’. There was no difference be-
tween groups in terms of the number of women who would
recommend the procedure to a friend, choose to have the same
procedure again or in retrospect would have preferred the
alternative treatment. In qualitative interviews, the preference
Fig. 1 Flow diagram showing
enrollment, preference for
treatment and follow-up of the
study patients
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patients reported less pain than the randomised ones, using
descriptions such as ‘uncomfortable’, ‘bearable’ and ‘better
than expected’. This group also reported little postoperative
pain describing it like ‘wind’ or ‘period pain’. They balanced
pain, which they mainly experienced short term, with the con-
venience of a fast response to their problem.
Additional treatments
There was no difference between groups in the number of
women using additional medical treatments for their bleeding,
or consulting a healthcare provider during the 6-month fol-
low-up period. Twenty-two women in the office group (7 %)
Table 1 Baseline
characteristics of the
patients
Office
polypectomy
(n = 324)
Inpatient
polypectomy
(n = 75)
p value
Age (years) Mean (SD) 53 (11) 51 (12) p = 0.2
BMI (kg/m2) Mean (SD) 31 (8)a 31 (8)b p = 0.7
Ethnicity White 263 (91 %) 54 (93 %) p > 0.9
Asian 12 (4 %) 2 (3 %)
Black 8 (3 %) 1 (2 %)
Other 6 (2 %) 1 (2 %)
Not given/not known 35 17
Recruiting centre BWHc 105 (32 %) 24 (32 %) p = 0.5
RHHd 60 (19 %) 18 (24 %)
Otherse 159 (49 %) 33 (44 %)
Predominant
bleeding
complaint at
randomisation
Post-menopausalf 155 (48 %) 37 (49 %) p = 0.2
Heavy menstrualg 75 (23 %) 23 (31 %)
Intermenstrualh 94 (29 %) 15 (20 %)
Site of uterine polyp Fundal 118 (36 %) 25 (33 %) p = 0.6
Non-fundal 206 (64 %) 50 (67 %)
Type of uterine polyp Glandular 229 (71 %) 53 (71 %) p > 0.9
Fibrous 95 (29 %) 22 (29 %)
Number of polyps 1 233 (72 %) 58 (77 %) p = 0.6
2 62 (19 %) 11 (15 %)
> = 3 29 (9 %) 6 (8 %)
Parity 0 49 (15 %) 18 (24 %) p = 0.4
1 35 (11 %) 6 (8 %)
2 121 (37 %) 26 (35 %)
3 50 (15 %) 9 (12 %)
> = 4 37 (11 %) 8 (11 %)
missing 32 (10 %) 8 (11 %)
Other benign
pathology
None 318 (98 %) 74 (99 %) p = 0.8
SMF/Adhesion/
Septum
– –
Adhesion/Septum – –
SMF 5 (2 %) 1 (1 %)
Septum 1 (<1 %) –
SMF submucosal fibroid
a Based on 56 values
b Based on 207 values
c Birmingham Women’s Hospital
d Royal Hallamshire Hospital, Sheffield
e 28 other centres: median recruitment = 4 (IQR = [2, 9])
f 16 (10 %) and 3 (8 %) of these women were currently taking a continuous combined ‘no bleed’ HRT in the office and
inpatient groups, respectively
g Includes one post-menopausal woman (1 %) on a sequential HRT (office group)
h Includes two post-menopausal women (2 %) on a sequential HRT (office group)
Gynecol Surg
Table 2 Operative details and complications
Office polypectomy Inpatient polypectomy Mean difference or OR (95 % CI)b, p value
Largest polyp size, cm
(median [IQR], n)a
1.1 [0.8–2.0], 286 1.0 [0.8–2.0], 57 0.0 (−0.2, 0.2), p > 0.9
Need for cervical dilation = yes 105/303 (35 %) 52/67 (78 %) 0.15 (0.08, 0.28), p < 0.001
Use of vaginal speculum = yes 152/301 (50 %) 53/60 (88 %) 0.13 (0.06, 0.31), p < 0.001
Use of local anaesthetic = yes 132/313 (42 %) 2/73 (3 %) 25.9 (6.2, 107), p < 0.001
Hysteroscopic removal = yes
(vs. blind)
246/299 (82 %) 36/64 (56 %) 3.6 (2.0, 6.4), p < 0.001
Scope diameter (mm) 4.0 [4.0–6.0], 201 5.5 [4.0–6.0], 42 −1.0 (−1.0, −1.0), p < 0.001
Method used to detach n = 287 n = 65 2.0 (1.2, 3.5)c, p = 0.02
Electrode 155 (54 %) 24 (37 %)
Mechanical 102 (36 %) 35 (54 %)
Combination 30 (10 %) 6 (9 %)
Method of retrieval n = 292 n = 62 5.6 (3.0, 10.4)d, p < 0.001
Hysteroscopic 193 (66 %) 16 (26 %)
Mechanical 69 (24 %) 43 (69 %)
Combination 11 (4 %) –
None 19 (7 %) 3 (5 %)
Surgeon grade = consultant 233/305 (76 %) 40/67 (60 %) 2.2 (1.3, 3.8), p = 0.005
Time taken for polypectomy, min
(median [IQR], n)
10 [5–15], 290 10 [7–15], 52 −1.5 (3.0, 0.0), p = 0.3
Time in office room/theatre, min
(median [IQR], n)
30 [20–35], 285 33 [25–45], 53 −6.0 (−10.0, −2.0), p = 0.003
Removal success n = 312 n = 73 1.4 (0.5, 3.9)f, p = 0.5
Complete 282 (90 %) 68 (93 %)
Partiale 22 (7 %) 3 (4 %)
Failede 8 (3 %) 2 (3 %)
Operative complications n = 302 n = 67
Vaso-vagal episode 17 (6 %) –
Patient discomfort 9 (3 %) –
Cervical trauma 1 (<1 %) 1 (1 %)
Uterine perforation – –
Otherg 1 (<1 %) –
Postoperative complications n = 301 n = 67
Vaso-vagal episode 14 (5 %) 2 (3 %)
Vomiting 3 (1 %) 2 (3 %)
Severe pain – 2 (3 %)
Further treatment/procedure given n = 292 n = 64
Mirena IUS 42 (14 %) 8 (13 %)
Tranexamic acid 9 (3 %) –
Progestogens 3 (1 %) –
Endometrial destruction 2 (1 %) –
Local oestrogen cream 2 (1 %) –
Mefenamic acid 1 (<1 %) 1 (2 %)
Contraceptive pill 1 (<1 %) –
Missing treatment name 2 (1 %) 1 (2 %)
Numbers in italics refer to the responses received for that particular question
n = number of responses
a Polyp size was estimated hysteroscopically
bMean difference < 0 indicates lower with office, similarly OR < 1 is lower with office. For skewed variables presented with medians, differences in
location between groups were calculated using Hodges-Lehmann estimates and Moses’ confidence intervals
c Odds ratio calculated from ‘electrode’ versus any other category
dOdds ratio calculated from ‘hysteroscopic’ versus any other category
e Nine (3 %) partial or failed patients in the office group and none in the inpatient group were immediately scheduled for reoperation. Six of these were
scheduled to be an inpatient. Partial or failed reasons in the office group (%’s given of the total number, 312): patient discomfort (9, 3 %), unable to
locate blindly (5, 2 %), unable to access under vision (4, 1 %), polyp too large (3, 1 %), failed hysteroscopy (1, <1 %), base cut but unable to remove (1,
<1 %), wide base unable to fully resect (1, <1 %), vaso-vagal episode (1, <1 %), difficult access to base of polyp (1, <1 %), missing reason (4, 1 %);
partial or failed reasons in the inpatient group (%’s given of the total number, 73): unable to access under vision (1, 1 %), unable to locate blindly (1,
1 %), deep sub-mucous fibroid polyp (1, 1 %), too broad base (1, 1 %), missing reason (1, 1 %)
f Odds ratio calculated from ‘partial’ or ‘failed’ versus complete
g Other complications: nausea
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Table 3 Results of quality of life assessments, bleeding and pain scores and procedure acceptability
Office polypectomy Inpatient polypectomy
Mean (SD, n) Mean (SD, n) Difference (95 % CI)a, p value Adjusted differenceh (95 % CI), p value
MMASb
Baseline 63 (26, 163) 61 (28, 37)
6 months 77 (25, 135)g 79 (25, 25)g −3 (−12, 7), p = 0.55 −4 (−14, 3), p = 0.18
EuroQol EQ-5Dc
Baseline 0.79 (0.26, 312) 0.72 (0.30, 71)
6 months 0.82 (0.25, 289)g 0.81 (0.30, 56) 0.00 (−0.07, 0.06), p = 0.88 0.01 (−0.05, 0.08), p = 0.64
EuroQol health thermometerd
Baseline 78 (18, 305) 75 (21, 71)
6 months 78 (19, 291) 79 (20, 57) −2 (−7, 3), p = 0.34 −1 (−4, 5), p = 0.81
Bleeding duration visual analogue scalee
Baseline 39 (26, 74) 38 (26, 23)
6 months 30 (28, 65)g 18 (19, 16)g −13 (−27, 2), p = 0.09 −13 (−27, 2), p = 0.09
Bleeding amount visual analogue scalef
Baseline 59 (28, 75) 58 (26, 23)
6 months 32 (28, 68)g 26 (27, 16)g −4 (−19, 11), p = 0.61 −3 (−20, 14), p = 0.72
Operation pain scores
During procedurei 42 (26, 296) – – –
60 min after procedurei 27 (24, 247) 20 (24, 60) −7 (−14, 0), p = 0.04 −8 (−11, −4), p = 0.03
On dischargei 22 (21, 276) 13 (18, 57) −9 (−15, −3), p = 0.003 −9 (−15, −3), p = 0.002
n (%) n (%) OR (95 % CI), p valuej Adjusted ORh (95 % CI), p value
Operation acceptability
Totally 194 (65 %) 52 (81 %)
Generally 48 (16 %) 9 (14 %) 0.21 (0.06, 0.69), p = 0.01k 0.19 (0.05, 0.70), p = 0.01k
Fairly 50 (17 %) 3 (5%)
Unacceptable 7 (2 %) 0 (–)
Exposure embarrassing?
Extremely 5 (2 %) 2 (3 %)
Moderately 30 (10 %) 7 (12 %) 1.4 (0.6, 3.0), p = 0.46l 1.4 (0.6, 3.7), p = 0.36l
A little 90 (30 %) 8 (13 %)
No 177 (59 %) 43 (72 %)
Recommend to a friend?
Yes/total 282/302 (93 %) 62/64 (97 %) 0.45 (0.10, 2.0), p = 0.28 Not possible to compute
Same treatment again?
Yes/total 283/300 (94 %) 62/63 (98 %) 0.27 (0.04, 2.1), p = 0.21 Not possible to compute
Preferred alternative treatment?
Yes/total 36/299 (12 %) 10/63 (16 %) 1.4 (0.7, 3.0), p = 0.41 1.5 (0.7, 3.5), p = 0.32
n number of responses
a Difference between groups at each time point adjusted for baseline score. Estimates of differences >0 favour office polypectomy, those <0 favour
inpatient polypectomy
bMenorrhagia Multi-Attribute Scale questionnaire. Scores range from 0 (severely affected) to 100 (not affected). Restricted to those with heavy
menstrual and intermenstrual bleeding only
c Health-related quality of life questionnaire. Scores range from −0.59 (health state worse than death) to 1.0 (perfect health state)
d Health-related quality of life questionnaire. Scores range 0 (worst imaginable health state) to 1.0 (best imaginable health state)
e Visual Analogue Scale score. Scores range from 0 (no days of bleeding in the last month) to 100 (bleeding every day in the last month). Restricted to
those with heavy menstrual bleeding only
f Visual Analogue Scale score. Scores range from 0 (no bleeding in the last month) to 100 (heaviest imaginable bleeding in the last month). Restricted to
those with heavy menstrual bleeding only
g p < 0.05 when compared with baseline score within group (by paired t test)
h See statistical methods section for details on adjustments
iVisual Analogue Scale score. Scores range from 0 (no pain at all) to 100 (worst imaginable pain). T test used for analysis
j Estimates of OR > 1 favour office polypectomy, those <1 favour inpatient polypectomy
k Totally acceptable/generally acceptable vs. fairly acceptable/unacceptable combined categories used to calculate odds ratio
l Extremely/moderately vs. a little/no combined categories used to calculate odds ratio
Gynecol Surg
and three in the inpatient group (4 %) had at least one further
polyp removal (OR = 1.75, 95%CI = 0.51, 6.00; p = 0.4). The
tota l number of women undergoing subsequent
gynaecological operations other than polyp removal was
higher with office polypectomy (27 [8 %] versus 3 [4 %])
but this difference was not statistically significant
(OR = 1.86, 95 % CI = 0.55, 6.35; p = 0.3). These operations
comprised the following in the office versus inpatient groups,
respectively: hysteroscopy, 9 (3 %) versus 2 (3 %); hysterec-
tomy, 9 (3%) versus 1 (2%) and endometrial ablation, 3 (1%)
versus 0. The other six operations were in the office group:
five cyst removals (2 %) and one ovary removal (<1 %).
Discussion
The results of this study demonstrate that women with abnor-
mal uterine bleeding and uterine polyps, who have a prefer-
ence for how they are treated, are more likely to choose office
polypectomy than an inpatient procedure. At 6 months, we
found no differences between office and inpatient treatment
in terms of treating abnormal uterine bleeding and over 80 %
women reported successful alleviation of symptoms, regard-
less of initial bleeding complaint. The duration and amount of
bleeding were significantly reduced following both office and
inpatient treatment, and no differences were identified accord-
ing to treatment preference. Similarly, a non-differential but
significant improvement in disease-specific quality of life was
seen following polypectomy, although generic quality of life
appeared only marginally improved.
There was no increased risk of partial or failed polypectomy
in the office group in the preference study which is contradic-
tory to the results of the randomised OPT study [14] which
found that office treatment was more likely to fail. This is likely
to be due to unknown confounders and the small sample size in
the inpatient group. Overall pain scores were still significantly
higher in the office group than in the inpatient group but these
differences were small and so their clinical significance is de-
batable; differences between groups in the amount of postop-
erative medication may also have affected this to an unknown
degree. Only 2 % of office patients felt that the procedure was
unacceptable; findings that are consistent with the concomitant
RCT. Not all women underwent their preferred treatment. We
can hypothesise that women may have changed their mind
about which treatment they wanted but we are unable to pro-
vide data as the reasons were not recorded.
In the qualitative interviews, women who had a preference
for office treatment appeared to report less pain than those
who were randomised to the office setting. Although the num-
ber of women who were interviewed was small, this may
suggest that women who choose to have the office treatment
are more motivated to tolerate and complete the procedure,
which may also contribute to the reduced number of failed
procedures in the office setting.
The strengths of this study include its size, the multicentre
design, a population representative of the UK demographic,
the relatively low rates of loss to follow-up and the tailoring of
assessment of outcomes to the primary complaint. As this was
a preference study, selection bias is an obvious limitation to
the interpretation of the results. However, statistical adjust-
ments were made for the obvious confounding factors includ-
ing type of bleeding, surgical experience, removal method and
the site, nature, size and number of uterine polyps.
In comparison to data from the parallel randomised con-
trolled trial [14], the overall level of failed polypectomy in both
groups was lower (9 versus 13%;OR= 0.64, 95%CI = 0.42 to
0.99; p = 0.05) and treatment success higher (82 versus 76 %;
OR = 1.4, 95 % CI = 1.0 to 2.0; p = 0.06). These findings are
unlikely to be due to differences in demographics of the two
studies as they were largely the same apart from a slightly older
population in the preference study (2.4 years, 95 % CI = 0.9 to
3.7). It is more likely to reflect the selection of more favourable,
better motivated women and technically ‘less challenging’
polyps to surgically remove in the office setting by the operat-
ing surgeon. However, the effect of counselling by individual
surgeons on patient preference for treatment setting or indeed
participation in the parallel randomised trial is unclear.
The 4:1 preference for office over inpatient polypectomy re-
sulted in a smaller inpatient cohort and therefore the result esti-
mates are less precise. Additional limitations of our preference
study include varying practise between clinicians and a small
number of participants failing to get their chosen treatment.
Office polyp treatment appears to be safe, feasible, accept-
able and effective for the treatment of abnormal uterine bleed-
ing in women expressing a preference for such treatment.
Although this treatment is becoming more widespread, it is
not universally available within national healthcare systems.
This study demonstrates that when office treatment is avail-
able, most women recognise the potential benefits of office
treatment and approximately 80 % would choose it over inpa-
tient treatment. In addition, this cohort study and the RCT
have both shown that removing uterine polyps appears to
alleviate abnormal uterine bleeding, for which data were pre-
viously lacking. Thus, there is evidence on both clinical and
patient preference grounds, to support prioritising the provi-
sion of ambulatory gynaecology services such as office hys-
teroscopic polypectomy. An important caveat, however, is that
women should be informed that office treatment may be as-
sociated with more pain and reduced acceptability compared
with scheduled inpatient approaches to treatment under gen-
eral anaesthesia, although they can be reassured that at least
eight out of ten women find the procedure to be totally or
generally acceptable. Although the preference study did not
demonstrate an increased failure rate in the office group, this is
likely to be due to confounding factors and the small inpatient
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group and as the RCT showed that failure was more likely,
women should be informed of this, to allow them to make an
informed decision about treatment setting. Future research
should be directed at evaluating the influence of clinical char-
acteristics and surgical technologies on the feasibility, accept-
ability and effectiveness of office hysteroscopic polypectomy.
This large, controlled observational study has shown that
the majority of women expressing a treatment preference
choose to have office treatment of uterine polyps associated
with abnormal uterine bleeding. The findings of the study are
subject to selection bias; however, they are consistent with the
robust data derived from the parallel RCT. The findings, in
particular the high levels of patient preference for office treat-
ment, support the conclusions of the RCT that ‘ambulatory’
gynaecological therapeutic services should be made more
widely available within healthcare systems. Currently, some
women are being denied a choice of treatment setting and
consequently are being subjected to the inconvenience and
greater burden of inpatient hospital treatment, which if offered
an alternative office treatment option, they could avoid.
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